Skip to main content

Advertisement

SpringerLink
Log in

Acne inversa

Hidradenitis suppurativa

  • Übersichtsarbeit
  • Published:
coloproctology Aims and scope

Zusammenfassung

Es wird im Einzelnen über Epidemiologie, Ätiopathogenese, Befund, Klassifikation, Lokalisation, Komplikationen, Symptomatik, Lebensqualität, Diagnostik und Differentialdiagnostik berichtet. Nur die operative Therapie der Acne inversa (AI) hat einen kurativen Effekt. Die konservative Therapie kann lediglich die Ausdehnung und Progredienz der AI reduzieren, so dass sich ein niedrigeres Stadium einstellt. Zur Behandlung der jeweiligen Stadien können folgende Empfehlungen gegeben werden:

• Stadium 1: topisch Clindamycin 10%, oral (kurzfristig) Tetracyclin;

• Stadium 2: oral (langfristig) Clindamycin und Rifampicin, Dapson, lokale Exzision;

• Stadium 3: weite Exzision mit sekundärer Wundheilung.

Abstract

The epidemiology, etiopathogenesis, clinical presentation, classification, localisation, complications symptoms, quality of life, and diagnosis are described. Only surgery has a curative effect. The conservative therapy reduces the extension and the progression of acne inversa. For therapy the following recommendations can be given:

• Degree 1: clindamycin (10% topical), tetracyclines (oral);

• Degree 2: clindamycin und rifampicin, dapsone (oral), excision;

• Degree 3: wide and radical excision, healing by secondary intention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Adams DR, Gordon KB, Devenyi AG, et al. Severe hidradenitis suppurativa treated with infliximab infusion. Arch Dermatol 2003;139:1540–2.

    Article  PubMed  Google Scholar 

  2. Boer J, van Gemert MJP. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol 1999;40:73–6.

    Article  PubMed  CAS  Google Scholar 

  3. Brown CF, Gallup DG, Brown VM. Hidradenitis supp. of the anogenital region: response to isotretinoin. Am J Obstet Gynecol 1988;158:12–5.

    PubMed  CAS  Google Scholar 

  4. Buckley DA, Rogers S. Cyclosporine-responsive hidradenitis suppurativa. J R Soc Med 1995;88:289–90.

    Google Scholar 

  5. Chow ETY, Mortimer PS. Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br J Dermatol 1992;126:415.

    Article  PubMed  CAS  Google Scholar 

  6. Church JM, Fazio VW, Lavery JC, et al. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn’s disease. Int J Colorectal Dis 1993;8:117–9.

    Article  PubMed  CAS  Google Scholar 

  7. Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 1983;22:325–8.

    Article  PubMed  CAS  Google Scholar 

  8. Dicken CH, Powell ST, Spear KL. Evaluation of isotretinoin treatment of hidradenitis suppurativa. J Am Acad Dermatol 1984;11:500–2.

    Article  PubMed  CAS  Google Scholar 

  9. Fröhlich D, Baaske D, Glatzel M. Radiotherapy of hidradenitis suppurativa - still valid today? Strahlenther Onkol 2000;176:286–9.

    PubMed  Google Scholar 

  10. Goldschmidt H. Röntgentherapie von Dermatosen, Hidradenitis suppurativa. Handbuch der Haut- und Geschlechtskrankheiten, Ergänzungsband V/2. Berlin-Heidelberg-New York: Springer, 1959:541–4.

    Google Scholar 

  11. Gupta AK, Ellis CN, Nickoloff BJ, et al. Oral ciclosporine in the treatment of inflammatory and non-inflammatory dermatoses: a clinical and immunohistopathologic study. Arch Dermatol 1990;126:339–50.

    Article  PubMed  CAS  Google Scholar 

  12. Hofer T, Itin PH. Acne inversa: eine Dapson-sensitive Dermatose. Hautarzt 2001;52:989–92.

    Article  PubMed  CAS  Google Scholar 

  13. Hogan DJ, Light MJ: Successful treatment of hidradenitis suppurativa with acitretin. J Am Acad Dermatol 1988;19:355–6.

    Article  PubMed  CAS  Google Scholar 

  14. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus surgical approach. In: Roenigk RK, Roenigk HH, eds. Dermatologic surgery. New York: Dekker, 1989:729–39.

    Google Scholar 

  15. Jemec GB. The symptomatology of hidradenitis suppurativa in women. Br J Dermatol 1988;119:345–50.

    Article  PubMed  CAS  Google Scholar 

  16. Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 1998;39:971–4.

    Article  PubMed  CAS  Google Scholar 

  17. Jemec GBE. Body weight in hidradenitis suppurativa. In: Marks R, Plewig G, eds. Acne and related disorders. London: Dunitz, 1989:375–6.

    Google Scholar 

  18. Jemec GBE. Methotrexate is of limited value in the treatment of hidradenitis suppurativa. Clin Exp Dermatol 2002;27:528–9.

    Article  PubMed  CAS  Google Scholar 

  19. Jemec GBE, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996;35:191–4.

    Article  PubMed  CAS  Google Scholar 

  20. Jones DH, Cunliffe WJ, King K. Hidradenitis suppurativa — lack of success with 13-cis-retinoic acid. Br J Dermatol 1982;107:252.

    Google Scholar 

  21. Katsanos KH, Christodoulou DK, Tsianos EV. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn’s disease patient. Am J Gastroenterol 2002;97:2155–6.

    Article  PubMed  Google Scholar 

  22. Konig H, Lehmann C, Rompel R, et al. Cigarette smoking as a triggering factor for hidradenitis suppurativa. Dermatology 1999;198:261–4.

    Article  PubMed  CAS  Google Scholar 

  23. Lebwohl B, Sapadin AN. Infliximab for the treatment of hidradenitis suppurativa. J Am Acad Dermatol 2003;49:275–6.

    Article  Google Scholar 

  24. Li M, Hunt MJ, Commens CA. Hidradenitis suppurativa, Dowling Degos disease, and perianal squamous cell carcinoma. Aust J Dermatol 1997;38:209–11.

    Article  CAS  Google Scholar 

  25. Lookingbill DP. Yield from a complete skin examination. Findings in 1157 new dermatology patients. J Am Acad Dermatol 1988;18:31–7.

    Article  PubMed  CAS  Google Scholar 

  26. Mahe A, Cisse JA, Faye O, et al. Skin diseases in Bamako (Mali). Int J Dermatol 1998;37:673–6.

    Article  PubMed  CAS  Google Scholar 

  27. Martinez F, Nos P, Benlloch S, et al. Hidradenitis suppurativa and Crohn’s disease: response to treatment with infliximab. Inflamm Bowel Dis 2001;7:323–6.

    Article  PubMed  CAS  Google Scholar 

  28. Mengesha YM, Holcombe TC, Hansen RC. Prepurbertal hidradenitis suppurativa: two cases reports and review of the literature. Pediatr Dermatol 1999;16:292–6.

    Article  PubMed  CAS  Google Scholar 

  29. Mortimer PS, Dawber RPR, Gales MA, et al. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986;115:263–8.

    Article  PubMed  CAS  Google Scholar 

  30. Norris JFB, Cunliffe WJ. Failure of treatment of familial widerspread hidradenitis suppurativa with isotretinoin. Clin Exp Dermatol 1986;11:579–83.

    Article  PubMed  CAS  Google Scholar 

  31. Perez-Dias D, Calvo-Serrano M, Martinez-Hijosa E, et al. Squamous cell carcinoma complicating perianal hidradenitis suppurativa. Int J Colorectal Dis 1995;10:225–8.

    Article  Google Scholar 

  32. Poli F, Jemec GBE, Revuz J. Clinical presentation. In: Jemec GBE, Revuz J, Leyden JJ, eds. Hidradenitis suppurativa. Berlin-Heidelberg: Springer, 2006:11–23.

    Chapter  Google Scholar 

  33. Rompel R, Peters J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg 2000;26:638–43.

    Article  PubMed  CAS  Google Scholar 

  34. Rose RF, Goodfield MJD, Clark SM. Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporine. Clin Exp Dermatol 2005;31:154–5.

    Article  Google Scholar 

  35. Rosi YL, Lowe L, Kang S. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn’s disease. J Dermatol Treat 2005;16:58–61.

    Article  CAS  Google Scholar 

  36. Sawers RS, Randall VA, Ebling FJB. Control of hidradenitis suppurativa in women using combined anti-androgen (cyproterone acetate) and oestrogen therapy. Br J Dermatol 1986;115:269–74.

    Article  PubMed  CAS  Google Scholar 

  37. Scheman AJ. Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report. Cutis 2002;69:287–8.

    PubMed  Google Scholar 

  38. Seegenschmiedt MH, Katalinic A, Makoski HB, et al. Radiotherapy for benign diseases: patterns of care study in Germany. Int J Radiat Oncol Biol Phys 2000;47:195–202.

    PubMed  CAS  Google Scholar 

  39. Stewart WD. Etretinate in other diseases of keratinization. In: The retinoids: a significant advance in dermatology. Medicines Publishing Foundation Symposium Series 14. Oxford. 1984:51–5.

  40. Sullivan TP, Welsh E, Kerdel FA, et al. Infliximab for hidradenitis suppurativa. Br J Dermatol 2003;149:1046–9.

    Article  PubMed  CAS  Google Scholar 

  41. Vahlquist A, Griffiths WAD. Retinoid therapy in hidradenitis suppurativa - report of a case. Retinoids Today Tom 1990;18:28–30.

    Google Scholar 

  42. Verneuil A. De l’hidrosadénite phlegmoneuse et des abcès sudoripares. Arch Gen Med 1864;115:327–37.

    Google Scholar 

  43. von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001;144:809–13.

    Article  PubMed  Google Scholar 

  44. von der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 2000;142:947–53.

    Article  Google Scholar 

  45. Williams ST, Busby RC, De Muth RJ, et al. Perineal hidradenitis suppurativa: presentation of two unusual complications and a review. Ann Plast Surg 1991;26:456–62.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätshautklinik, Aachen, Germany

    Volker Wienert

  2. Universitätshautklinik, Pauwelsstraße 30, 52074, Aachen, Germany

    Volker Wienert

Authors
  1. Volker Wienert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Volker Wienert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wienert, V. Acne inversa. Coloproctol 31, 175–179 (2009). https://doi.org/10.1007/s00053-009-0019-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00053-009-0019-5

Schlüsselwörter:

Key Words:

Search

Navigation